Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Nephrology

Diagnosis and Distinguishing from Look-alikes

At a Glance

FRTS3 is diagnosed by confirming proximal tubule dysfunction with blood and urine tests and identifying a pathogenic or likely pathogenic EHHADH variant. Doctors also use genetic testing and targeted tests to rule out cystinosis, Dent disease, Lowe syndrome, and other Fanconi syndromes.

Because many different conditions can cause the kidneys to “waste” nutrients, a diagnosis of Fanconi renotubular syndrome 3 (FRTS3) requires more than just a simple urine test. Doctors must determine that your proximal tubules are not working correctly and then use genetic testing to identify if the EHHADH gene is the cause [1][2].

Confirming Fanconi Syndrome

The first step is evaluating whether you have Fanconi syndrome—a general term for the failure of the kidney’s proximal tubules. This is done through blood and urine tests that look for a specific “signature” of nutrient loss [1][3]:

  • Glucosuria: Finding sugar in the urine while your blood sugar is perfectly normal [3].
  • Phosphaturia: Wasting phosphate in the urine, which can lead to low blood levels (hypophosphatemia) and bone problems [4][5].
  • Aminoaciduria: The presence of amino acids (protein building blocks) in the urine [3].
  • Tubular Proteinuria: Detecting specific small proteins, like beta-2 microglobulin, which is a useful marker that can suggest proximal tubular dysfunction [6][7].
  • Renal Tubular Acidosis (RTA): A buildup of acid in the blood because the kidneys are not reclaiming enough bicarbonate [8][9].

Distinguishing FRTS3 from “Look-alikes”

Many conditions look like FRTS3 at first glance. However, identifying the exact cause is vital because some of these “look-alikes” require very different treatments [10][11].

1. Nephropathic Cystinosis

This is the most common inherited cause of Fanconi syndrome in children [12]. Unlike FRTS3, cystinosis is a systemic disease where the amino acid cystine builds up in all organs, including the eyes [13].

  • How it’s ruled out: Doctors use a leukocyte cystine assay (a blood test) to check for cystine buildup and an eye exam to look for crystals in the cornea [12][14].

2. Dent Disease and Lowe Syndrome

These are caused by mutations in different genes (CLCN5 or OCRL) and are usually “X-linked,” meaning they primarily affect males [15][16].

  • Key Differences: Patients with Dent disease often have very high levels of calcium in their urine (hypercalciuria) and kidney stones, which are less common in FRTS3 [15][17]. Lowe syndrome also involves cataracts and developmental delays [16].

3. Other FRTS Types

Other genetic mutations (like GATM for FRTS1 or HNF4A for FRTS4) can also cause Fanconi syndrome [18]. For example, FRTS4 often involves babies being born very large with low blood sugar, which is not typical for FRTS3 [19][20].

The Role of Genetic Testing

Because the physical symptoms and lab results of these conditions overlap so much, a compatible clinical picture plus a pathogenic or likely pathogenic EHHADH variant supports the diagnosis of FRTS3 [21][11].

It is important to note that a genetic test may return a pathogenic variant, a benign variant, or a “variant of uncertain significance” (VUS). A VUS does not definitively establish the diagnosis [22][23]. Genetic counseling can help you interpret these results and discuss the targeted testing of relatives.

Possible Diagnostic Evaluations

If your doctor suspects FRTS3 or another tubulopathy, they may order several tests depending on your age and symptoms. These are not all mandatory, but represent a common diagnostic toolkit:

  • Comprehensive Metabolic Panel: To check blood levels of potassium, bicarbonate, and renal function (eGFR). (Note: Serum phosphate, magnesium, and uric acid usually must be ordered separately) [3].
  • Urinalysis and Paired Serum/Urine Studies: To measure the exact amount of sugar, protein, and phosphate being lost. Fractional excretion tests may be used instead of a 24-hour urine collection [4][24].
  • Urine Protein Electrophoresis: To confirm if the protein is “tubular” in origin [25].
  • Leukocyte Cystine Assay: To rule out cystinosis if clinically indicated [12].
  • Genetic Panel: A test that looks at EHHADH, CLCN5, CTNS, GATM, and other “tubulopathy” genes simultaneously [21].
  • Renal Ultrasound: To check for kidney stones or calcium deposits (nephrocalcinosis) [17][26].

Common questions in this guide

How is Fanconi renotubular syndrome 3 diagnosed?
Doctors first confirm Fanconi syndrome by checking for proximal tubule losses in blood and urine, such as glucose in the urine despite normal blood sugar, phosphate loss, amino acids, small proteins, or low bicarbonate. A compatible clinical picture plus a pathogenic or likely pathogenic variant in the EHHADH gene supports an FRTS3 diagnosis.
What does an EHHADH genetic test result mean?
A pathogenic or likely pathogenic EHHADH variant can support FRTS3 when the person's findings fit the condition. A benign variant does not cause FRTS3, while a variant of uncertain significance does not confirm or rule out the diagnosis by itself.
Which tests help rule out cystinosis?
Doctors may order a leukocyte cystine assay, a blood test that measures cystine buildup in white blood cells. An eye examination can also look for corneal crystals, because cystinosis can affect multiple organs and the eyes.
How is FRTS3 different from Dent disease or Lowe syndrome?
FRTS3 is linked to EHHADH, while Dent disease and Lowe syndrome are linked to different genes. Dent disease is often associated with marked urinary calcium loss and kidney stones, whereas Lowe syndrome may include cataracts and developmental delays. Genetic testing helps distinguish these conditions because their kidney findings can overlap.
What blood and urine tests are used when FRTS3 is suspected?
Evaluation may include a metabolic panel, serum phosphate, magnesium and uric acid, urinalysis, paired blood-and-urine measurements, and urine protein electrophoresis. Doctors may also use fractional excretion tests, a genetic panel, and kidney ultrasound to investigate the cause or look for findings such as stones.
Should relatives be tested for FRTS3?
FRTS3 can be inherited in an autosomal dominant pattern, so close relatives may benefit from genetic counseling and targeted testing for the family's known EHHADH variant. A genetics professional can explain who should be tested and what the results mean.

Get notified when new evidence is published on Fanconi renotubular syndrome 3.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Proximal renal tubular acidosis with and without Fanconi syndrome.

    Kashoor I, Batlle D

    Kidney research and clinical practice 2019; (38(3)):267-281 doi:10.23876/j.krcp.19.056.

    PMID: 31474092
  2. 2

    Adult Idiopathic Renal Fanconi Syndrome: A Case Report.

    Park DJ, Jang KS, Kim GH

    Electrolyte & blood pressure : E & BP 2018; (16(2)):19-22 doi:10.5049/EBP.2018.16.2.19.

    PMID: 30899310
  3. 3

    Fanconi Syndrome.

    Foreman JW

    Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.

    PMID: 30454741
  4. 4

    Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management.

    Wang C, Zhou Y, Song L, et al.

    Frontiers in medicine 2022; (9()):945244 doi:10.3389/fmed.2022.945244.

    PMID: 36186816
  5. 5

    Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene.

    Improda N, Rosanio FM, Annicchiarico Petruzzelli L, et al.

    Frontiers in endocrinology 2025; (16()):1553032 doi:10.3389/fendo.2025.1553032.

    PMID: 40225330
  6. 6

    Fumaric acid ester-induced renal Fanconi syndrome: evidence of mitochondrial toxicity.

    Wan ER, Siew K, Heptinstall L, Walsh SB

    Clinical kidney journal 2021; (14(9)):2085-2089 doi:10.1093/ckj/sfaa270.

    PMID: 35261762
  7. 7

    Fanconi Syndrome Associated with Hyponatremia in Two Patients with Legionella Pneumonia.

    Ryuge A, Ito Y, Yamakawa T, et al.

    Internal medicine (Tokyo, Japan) 2016; (55(23)):3479-3484 doi:10.2169/internalmedicine.55.7297.

    PMID: 27904113
  8. 8

    Rickets in proximal renal tubular acidosis: a case series of six distinct etiologies.

    Singhania P, Dhar A, Deshpande A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(9)):879-885 doi:10.1515/jpem-2023-0155.

    PMID: 37434360
  9. 9

    An Interesting Case of Acquired Renal Fanconi Syndrome.

    Senthilnathan S, Nallusamy G, Varadaraj P

    Cureus 2024; (16(7)):e65208 doi:10.7759/cureus.65208.

    PMID: 39176318
  10. 10

    Inherited Fanconi syndrome.

    Albuquerque ALB, Dos Santos Borges R, Conegundes AF, et al.

    World journal of pediatrics : WJP 2023; (19(7)):619-634 doi:10.1007/s12519-023-00685-y.

    PMID: 36729281
  11. 11

    Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.

    Ragate DC, Memon SS, Karlekar M, et al.

    Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.

    PMID: 38310177
  12. 12

    Long-term outcomes in nephropathic cystinosis: a review.

    Chang HE, Hossain MS, Song C, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(2)):277-296 doi:10.1007/s00467-025-06790-6.

    PMID: 40369127
  13. 13

    CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.

    Papizh S, Serzhanova V, Filatova A, et al.

    BMC nephrology 2019; (20(1)):400 doi:10.1186/s12882-019-1589-2.

    PMID: 31672123
  14. 14

    Therapeutic strategies in cystinosis: A focus on cysteamine and beyond.

    Santoro A, Ferrara YV, De Angelis A

    Experimental and molecular pathology 2025; (144()):104995 doi:10.1016/j.yexmp.2025.104995.

    PMID: 40912033
  15. 15

    Clinical manifestation and genetic findings in three boys with low molecular Weight Proteinuria - three case reports for exploring Dent Disease and Fanconi syndrome.

    Duan N, Huang C, Pang L, et al.

    BMC nephrology 2021; (22(1)):24 doi:10.1186/s12882-020-02225-6.

    PMID: 33430795
  16. 16

    The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

    De Matteis MA, Staiano L, Emma F, Devuyst O

    Nature reviews. Nephrology 2017; (13(8)):455-470 doi:10.1038/nrneph.2017.83.

    PMID: 28669993
  17. 17

    Skeletal Consequences of Nephropathic Cystinosis.

    Florenzano P, Ferreira C, Nesterova G, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(10)):1870-1880 doi:10.1002/jbmr.3522.

    PMID: 29905968
  18. 18

    Novel Fanconi renotubular syndromes provide insights in proximal tubule pathophysiology.

    Lemaire M

    American journal of physiology. Renal physiology 2021; (320(2)):F145-F160 doi:10.1152/ajprenal.00214.2020.

    PMID: 33283647
  19. 19

    Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular Syndrome.

    Emma F, Böckenhauer D, Mallett AJ, et al.

    Kidney international reports 2026; (11(8)):106616 doi:10.1016/j.ekir.2026.106616.

    PMID: 42440446
  20. 20

    Hepatocyte Nuclear Factor-4 Alfa Mutation Associated with Hyperinsulinaemic Hypoglycaemia and Atypical Renal Fanconi Syndrome: Expanding the Clinical Phenotype.

    Improda N, Shah P, Güemes M, et al.

    Hormone research in paediatrics 2016; (86(5)):337-341 doi:10.1159/000446396.

    PMID: 27245055
  21. 21

    Genetic Screening of Patients With Inherited Fanconi Syndrome.

    Inoki Y, Sakakibara N, Yamamoto A, et al.

    Kidney international reports 2026; (11(7)):106576 doi:10.1016/j.ekir.2026.106576.

    PMID: 42282999
  22. 22

    The recurrent p.Glu3Lys variant in EHHADH is responsible for Fanconi syndrome with early liver dysfunction and mitochondrial abnormalities.

    Rollier P, Cospain A, Barth M, et al.

    Molecular genetics and metabolism reports 2025; (43()):101214 doi:10.1016/j.ymgmr.2025.101214.

    PMID: 40242153
  23. 23

    A puzzling renal Fanconi syndrome.

    Haydock L, Hureaux M, Hoffmann M, et al.

    Clinical kidney journal 2025; (18(8)):sfae408 doi:10.1093/ckj/sfae408.

    PMID: 40800210
  24. 24

    A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.

    Yamaguchi S, Maruyama T, Wakino S, et al.

    BMC nephrology 2015; (16()):187 doi:10.1186/s12882-015-0184-4.

    PMID: 26554665
  25. 25

    The Spectrum of Kidney Diseases in Children Associated with Low Molecular Weight Proteinuria.

    Salihu S, Tosheska K, Aluloska N, et al.

    Open access Macedonian journal of medical sciences 2018; (6(5)):814-819 doi:10.3889/oamjms.2018.221.

    PMID: 29875851
  26. 26

    Refractory Rickets: Evaluation and Management.

    Krishnamurthy S

    Indian journal of pediatrics 2026; (93(6)):612-620 doi:10.1007/s12098-026-06032-z.

    PMID: 41741919

This page explains how clinicians evaluate FRTS3 and distinguish it from other causes of Fanconi syndrome for informational purposes only and does not constitute medical advice. A nephrologist or genetics professional should interpret your test results and advise you about diagnosis.